Tag

AstraZeneca

Manufacturing Strategies for Sustainable Global Growth: Building a Global Sustainable Supply Operation for the Future Leveraging Digital and Innovation
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Manufacturing Strategies for Sustainable Global Growth: Building a Global Sustainable Supply Operation for the Future Leveraging Digital and Innovation

— Per AlfredssonSVP, Global Biologics Operations AstraZeneca and President AstraZeneca ABAstraZeneca As Senior Vice President, Global Biologics Operations, Per leads the global biologics operations network, which includes five internal manufacturing sites across four countries, as well as the external biologics supply network. Since April 2020, Per has also served as co-lead for the COVID-19 vaccine program, AZD1222, during which he has led the rapid establishment and start-up of a complex manufacturing network of more than 20 partners across more than 15 countries. Throughout his 24 years within AstraZeneca, Per has significant global experience across all aspects of manufacturing and supply…

Continue reading
Managing Innovation and Variability in a Growth Environment
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Managing Innovation and Variability in a Growth Environment

 How the pandemic impacted the structure and responsiveness of our global networks Responding to new geographic fluctuation of demand by disease states and patient delivery The challenges and opportunities posed by new product innovation and managing lifecycles — Andy Wirths SVP Supply Americas AstraZeneca Andrew (Andy) Wirths is a senior pharmaceutical operations leader with over 30 years’ experience in the industry spanning small and large molecule manufacturing. Andy joined AstraZeneca in 2015 and is currently Senior Vice President, Americas Supply, where he is responsible for overseeing the manufacturing operations of 8 sites in North and South America. Previously Andy…

Continue reading
Managing Innovation and Variability in a Growth Environment
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Managing Innovation and Variability in a Growth Environment

How the pandemic impacted the structure and responsiveness of our global networks Responding to new geographic fluctuation of demand by disease states and patient delivery The challenges and opportunities posed by new product innovation and managing lifecycles — Linzell Harris SVP Global Supply Chain and Strategy AstraZeneca Linzell Harris is senior vice president of Global Supply Chain and Strategy for AstraZeneca, with overall responsibility for the development and execution of the end to end supply chain platform and product supply strategies. In addition, he is responsible for ensuring the strategic development of network designs and supply chain capabilities supporting the…

Continue reading
Fighting COVID-19 with Innovation – What We Have Achieved, What We Have Learned, and What Comes Next
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Fighting COVID-19 with Innovation – What We Have Achieved, What We Have Learned, and What Comes Next

Offering an overview of how our industry responded to the global pandemic Highlighting how our organization adapted our existing processes and programs to continue to work under extraordinary circumstances Discussing some of the key takeaways and lessons learned from the past year and a half Where do we go from here? How will AstraZeneca and the biopharmaceutical industry at large move forward from here? What are we doing today to pave the way to those objectives? Pam Cheng EVP, President Global Operations & IT AstraZeneca Pam Cheng joined AstraZeneca in 2015 as executive vice president of Global Operations and Information…

Continue reading
Fighting COVID-19 with Innovation – A Race Against Time
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Fighting COVID-19 with Innovation – A Race Against Time

Pam Cheng EVP, President Global Operations & IT AstraZeneca Pam Cheng joined AstraZeneca in 2015 as executive vice president of Global Operations and Information Technology (IT), guiding the company’s manufacturing, supply chain, procurement, and IT across 18 countries and leading a team of over 19,000. Under her leadership, AstraZeneca Global Operations has transformed significantly driving top performance across the business while delivering value back to the enterprise. The next phase of transformation includes the convergence of operational excellence and digital innovation, building the ‘Factory of the Future’. Before AstraZeneca she spent 18 years in global manufacturing, supply chain, and commercial…

Continue reading
Knowing and Protecting Your Assets
Uncategorized, VIDEO

Knowing and Protecting Your Assets

Discussing options for biomanufacturing capacity management: Effective strategies for capacity utilization Spreading capacity among and across different business partners When is the right time to hedge with CMOs? Understanding the attraction, retention, and development trends for talent assets Illustrating these trends with metrics and examples from AstraZeneca’s own experience — Darren Dasburg currently serves as VP & Head, Learning and Development Global Operation at AstraZeneca. Bringing over 30 years of professional experience in a variety of settings, he was appointed Vice President-Site Head for the Boulder Manufacturing Center in September 2015 when AstraZeneca/MedImmune acquired the former Amgen biologics production facility. Previously,…

Continue reading